Skip to main content

Table 1 Demographic and clinical characteristics of the participants

From: The midterm effect of exercise capacity and quality of life in adult patients who underwent hybrid transthoracic device closure of ventricular septal defects

Item

Patient group

Control group

P-value

Age (years)

33.8 ± 9.3

32.9 ± 9.2

0.768

Male (%)

30(54.5%)

32(55.2%)

0.832

Weight (kg)

66.5 ± 9.3

63.4 ± 9.0

0.853

Height (cm)

168.5 ± 7.0

169.0 ± 7.5

0.043

Married

48(87.3%)

50(86.2%)

0.513

BMI (kg/m2)

22.8 ± 4.5

22.0 ± 5.2

0.378

Qp/Qs

1.7 ± 0.5

Systolic PAP (mmhg)

39 ± 11.0

VSD size (mm)

7.0 ± 1.3

Type of the VSD

   

Perimembranous VSD

49(89.1%)

  

Subarterial VSD

5(9.1%)

  

Muscular VSD

1(1.8%)

  
  1. VSD: ventricular septal defect; PAP: Pulmonary artery pressure